Advertisement
Screener

BIOCERES CROP SOLUTIONS CORP. (BIOX) Cash Flows From Used In Financing Activities

2.8 / 5 stars · 68/120 Roast Me

BIOCERES CROP SOLUTIONS CORP. Cash Flows From Used In Financing Activities

BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Cash Flows From Used In Financing Activities of -$46.70 million for the 6-month period ending 2025-12-31, per its 6-K filed 2026-03-13.

Financial Statements › Cash Flow › Financing Activities

ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-03-13

  • BIOCERES CROP SOLUTIONS CORP. cash flows from used in financing activities for the quarter ending 2025-12-31 was -$17.99M, a 377.41% decline year-over-year.
  • BIOCERES CROP SOLUTIONS CORP. cash flows from used in financing activities for the quarter ending 2025-09-30 was -$28.71M.
  • BIOCERES CROP SOLUTIONS CORP. cash flows from used in financing activities for the quarter ending 2025-06-30 was -$25.71M, a 583.16% decline year-over-year.
  • BIOCERES CROP SOLUTIONS CORP. cash flows from used in financing activities for the quarter ending 2025-03-31 was -$12.68M, a 216.36% decline year-over-year.
Period endCash Flows From Used In Financing Activities 3 monthCash Flows From Used In Financing Activities 6 monthCash Flows From Used In Financing Activities 6 month as first filedCash Flows From Used In Financing Activities 9 monthCash Flows From Used In Financing Activities 12 month
2025-12-31-$17.99M
derived: 6-K 6 month − 6-K 3 month · filed 2026-03-13
-$46.70M
6-K · filed 2026-03-13
-$72.41M
derived: sum of 3 quarters · filed 2026-03-13
-$85.10M
derived: sum of 4 quarters · filed 2026-03-13
2025-09-30-$28.71M
6-K · filed 2025-11-26
-$54.42M
derived: sum of 2 quarters · filed 2025-11-26
-$67.10M
derived: sum of 3 quarters · filed 2025-11-26
-$60.62M
derived: sum of 4 quarters · filed 2026-03-13
2025-06-30-$25.71M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
-$38.39M
derived: sum of 2 quarters · filed 2025-11-10
-$31.91M
derived: sum of 3 quarters · filed 2026-03-13
-$50.71M
20-F · filed 2025-11-10
2025-03-31-$12.68M
derived: 6-K 9 month − 6-K 6 month · filed 2025-06-20
-$6.20M
derived: sum of 2 quarters · filed 2026-03-13
-$25.00M
6-K · filed 2025-06-20
-$19.67M
derived: sum of 4 quarters · filed 2026-03-13
2024-12-31$6.49M
derived: 6-K 6 month − 6-K 3 month · filed 2026-03-13
-$12.31M
6-K · filed 2026-03-13
-$6.99M
derived: sum of 3 quarters · filed 2026-03-13
$3.91M
derived: sum of 4 quarters · filed 2026-03-13
2024-09-30-$18.80M
6-K · filed 2025-11-26
-$13.48M
derived: sum of 2 quarters · filed 2025-11-26
-$2.58M
derived: sum of 3 quarters · filed 2025-11-26
-$1.88M
derived: sum of 4 quarters · filed 2025-11-26
2024-06-30$5.32M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
$16.22M
derived: sum of 2 quarters · filed 2025-11-10
$16.92M
derived: sum of 3 quarters · filed 2025-11-10
-$10.06M
20-F · filed 2025-11-10
2024-03-31$10.90M
derived: 6-K 9 month − 6-K 6 month · filed 2025-06-20
$11.60M
derived: sum of 2 quarters · filed 2025-06-20
-$15.38M
6-K · filed 2025-06-20
-$12.05M
derived: sum of 4 quarters · filed 2025-11-10
2023-12-31$698.70K
derived: 6-K 6 month − 6-K 3 month · filed 2025-02-28
-$26.28M
6-K · filed 2025-02-28
-$22.95M
derived: sum of 3 quarters · filed 2025-11-10
-$33.67M
derived: sum of 4 quarters · filed 2025-11-10
2023-09-30-$26.98M
6-K · filed 2024-11-27
-$23.65M
derived: sum of 2 quarters · filed 2025-11-10
-$34.37M
derived: sum of 3 quarters · filed 2025-11-10
-$34.25M
derived: sum of 4 quarters · filed 2025-11-10
2023-06-30$3.32M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
-$7.39M
derived: sum of 2 quarters · filed 2025-11-10
-$7.27M
derived: sum of 3 quarters · filed 2025-11-10
$32.95M
20-F · filed 2025-11-10
2023-03-31-$10.72M
derived: 6-K 9 month − 6-K 6 month · filed 2024-05-29
-$10.60M
derived: sum of 2 quarters · filed 2024-05-29
$29.63M
6-K · filed 2024-05-29
$31.22M
derived: sum of 4 quarters · filed 2024-10-30
2022-12-31$119.78K
derived: 6-K 6 month − 6-K 3 month · filed 2024-02-28
$40.34M
6-K · filed 2024-02-28
$41.93M
derived: sum of 3 quarters · filed 2024-10-30
$37.39M
derived: sum of 4 quarters · filed 2024-10-30
2022-09-30$40.22M
6-K · filed 2023-11-29
$41.81M
derived: sum of 2 quarters · filed 2024-10-30
$37.27M
derived: sum of 3 quarters · filed 2024-10-30
2022-06-30$1.59M
derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30
-$2.95M
derived: sum of 2 quarters · filed 2024-10-30
$14.82M
20-F · filed 2024-10-30
2022-03-31-$4.54M
derived: 6-K 9 month − 6-K 6 month · filed 2023-05-24
$13.23M
6-K · filed 2023-05-24
2021-12-31$17.78M
6-K · filed 2023-02-28
2021-06-30$7.36M
20-F · filed 2023-11-14
2020-12-31$12.17M
6-K · filed 2022-02-25
$13.78M
6-K · filed 2021-02-26
2020-06-30$33.53M
20-F · filed 2022-10-28
2019-12-31$7.09M
6-K · filed 2021-02-26
$1.29M
6-K/A · filed 2020-03-17
2019-06-30-$26.95M
20-F · filed 2021-10-29
2018-12-31$5.21M
6-K/A · filed 2020-03-17
2018-06-30-$10.46M
20-F · filed 2020-10-21
2017-06-30$1.17M
20-F · filed 2019-10-24
2016-12-31$43.97M
20-F · filed 2019-10-24